RRA
ANIP icon

Round Rock Advisors’s ANI Pharmaceuticals ANIP Stock Holding History

Round Rock Advisors’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$669K Hold
8,076
– – 0.09% 179
2026
Q1 		$621K Hold
8,076
– – 0.1% 169
2025
Q4 		$638K Buy
8,076
+3,146
+64% +$272K 0.1% 164
2025
Q3 		$468K Buy
+4,930
New +$402K 0.07% 185

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Round Rock Advisors's ANIP Position: Q2 2026 in Review

Round Rock Advisors held its ANI Pharmaceuticals (ANIP) position steady in Q2 2026 at 8,076 shares worth $669K. The position accounts for 0.09% of the portfolio, ranked #179.

Round Rock Advisors first reported a position in ANIP in Q3 2025 and has held it in 4 quarters since. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Round Rock Advisors held 8,076 shares of ANI Pharmaceuticals worth $669K as of Q2 2026.
  • Round Rock Advisors left its ANI Pharmaceuticals share count unchanged in Q2 2026.
  • ANI Pharmaceuticals made up 0.09% of Round Rock Advisors's portfolio in Q2 2026, its #179 holding.
  • Round Rock Advisors first reported a position in ANI Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Round Rock Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.